Norbornyl Substituted Adenosine Receptor Ligands: Potential Cardiovascular Pharmaceuticals

  • Scammells, Peter (Primary Chief Investigator (PCI))
  • Baker, Stephen G. (Chief Investigator (CI))

    Project: Research

    Project Description

    Adenosine receptor agonists with high potency and selectivity and a moderate duration of action have been targeted as potential drugs for the therapy of cardiac arrhythmias such as PSVT. A series of related xanthines that block the adenosine receptor will also be prepared. Compounds of this type act as diureics and have potential application in the treatment of congestive heart failure.
    StatusActive
    Effective start/end date1/10/01 → …

    Funding

    • Australian Research Council (ARC): AUD86,472.00